A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
Jonsson Comprehensive Cancer Center
University of Wisconsin, Madison
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Massachusetts General Hospital
University of Louisville
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
Indiana University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northwestern University
Northwestern University
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey